Skip to content

Short Term Evaluation of SLIC Screw in Treatment of Scapholunate Injury

Multicenter Retrospective-prospective Short-term Evaluation of the SLIC Screw System in Subjects Requiring Treatment for Acute Scapholunate Injury

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02579694
Enrollment
9
Registered
2015-10-20
Start date
2015-09-30
Completion date
2017-06-30
Last updated
2017-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Scapholunate Injury

Brief summary

The purpose of this retrospective-prospective clinical evaluation is to determine whether the SLIC Screw System provides provisional fixation to allow biological healing of the scapholunate interval.

Interventions

DEVICEAcumed Scapholunate Intercarpal Screw

Evaluation of provisional fixation to allow biologic healing of the scapholunate interval

Sponsors

Acumed, LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subjects willing and able to comprehend and sign Informed Consent * Subjects who have received the SLIC screw as part of the treatment for scapholunate ligament repair or scapholunate reduction * Subjects with acute scapholunate injury, classified with Garcia-Elias Stage 1-4, OR Geissler Stage 1-3 * Subjects \>18 years of age at the time of surgery

Exclusion criteria

* Subject diagnosed with chronic scapholunate injury * Subjects who underwent previous scapholunate procedure on the study wrist before implantation of the SLIC Screw System * Subjects with active or latent infection at the time of surgery * Subjects with sepsis at the time of surgery * Subjects diagnosed with osteoporosis at the time of surgery * Subjects with insufficient quantity and/or quality of bone * Subjects with cartilage degeneration on the bones at the time of surgery * Subjects with absence of potential for soft tissue healing at time of surgery, as documented by the investigator. * Female Subjects known to be pregnant * Subjects who were unable to follow postoperative care instructions, specifically, activity levels * Subjects who are unable or unwilling to return for postoperative study visits

Design outcomes

Primary

MeasureTime frameDescription
Comparison of reported VAS pain from preoperative to post-planned explantation12 monthsPlanned removal of provisional device recommended between six and 9 months; 12-month analysis will capture time to planned removal.
Time to planned explantation is operationally defined as the time in days between device implantation and planned removal of an intact device12 months
The proportion of devices where removal is attributed to healing and not device failure12 months

Secondary

MeasureTime frameDescription
Complication rates over time12 months
Comparison of range of motion in degrees from preoperative values12 monthsFlexion, Extension, Radial Deviation, Ulnar Deviation
Comparison of grip strength in kg from preoperative values12 months
Radiographic evaluation of device integrity12 monthsDevice integrity defined as no device breakage or separation
Subject satisfaction based on a five-point scale from preoperative12 months
Comparison of scapholunate angle from preoperative through radiographic evaluation12 months
Comparison of scapholunate joint space from preoperative through radiographic evaluation12 months
Comparison of reported VAS pain from preoperative values12 months
Radiographic evaluation of radiolucency12 months
Radiographic evaluation of osteolysis12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026